RealTime Software Solutions Announces Acquisition of Devana Solutions
RealTime Software Solutions has announced its acquisition of Devana Solutions, an SaaS provider specializing in clinical trial workflow and analytics solutions.
By integrating Devana's solutions into RealTime's Site Operations Management System (SOMS), clinical research organizations will be able to access a suite of capabilities that bridge centralized operations with site-based clinical teams. The combination of these solutions establishes connectivity between Devana's business development and data analytics platform and RealTime's suite of products that includes CTMS, eRegulatory solutions, eSource, eConsent, payments, texting solutions, the MyStudyManager Participant Portal, and other eClinical solutions and services.
Originally designed to address the operational gap before participant recruitment, screening and CTMS-managed clinical workflows, Devana's PROPEL products automate pipeline management and trial startup workflows while capturing timing and performance metrics for analysis and action.
Reference
RealTime Software Solutions Strengthens its Position in the Clinical Research Industry with the Acquisition of Devana Solutions. (2023, July 6). Cision PR Newswire.
FDA Delays Review of BLA Submission for Moderna's Novel Respiratory Syncytial Virus Vaccine
May 10th 2024Administrative constraints cause FDA to push back its review of data from a pivotal Phase III trial (NCT05127434), which demonstrated favorable clinical safety and efficacy for mRNA-1345, an investigational vaccine found to reduce the incidence of RSV-associated lower respiratory tract disease.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
